603882 金域医学
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.916-2.465-4.8607.57136.885
总资产报酬率 ROA (%)2.029-1.733-3.4415.01522.357
投入资产回报率 ROIC (%)2.552-2.192-4.4246.97533.452

边际利润分析
销售毛利率 (%)36.71234.74133.14636.47843.128
营业利润率 (%)9.314-2.154-3.8018.89721.628
息税前利润/营业总收入 (%)8.988-3.074-6.1408.65721.376
净利润/营业总收入 (%)7.337-2.962-5.7687.45818.383

收益指标分析
经营活动净收益/利润总额(%)88.685-118.996-100.489122.168106.417
价值变动净收益/利润总额(%)-2.688-0.94415.47535.522-0.325
营业外收支净额/利润总额(%)-4.39828.49037.707-2.631-0.798

偿债能力分析
流动比率 (X)3.1323.2383.2783.0732.327
速动比率 (X)3.0383.1473.1892.9812.239
资产负债率 (%)29.42328.59028.06827.36536.104
带息债务/全部投入资本 (%)10.89810.3598.1214.9664.747
股东权益/带息债务 (%)798.450849.2021,105.7561,855.2511,940.682
股东权益/负债合计 (%)234.831245.063251.139259.693172.122
利息保障倍数 (X)134.29449.386159.115-701.395-263.228

营运能力分析
应收账款周转天数 (天)213.211231.274243.646260.537135.972
存货周转天数 (天)18.34317.58316.72221.68415.346